iPLEDGE is a risk management program designed to help eliminate fetal exposure to:
Correct Answer: A
iPLEDGE is a REMS (Risk Evaluation and Mitigation Strategy) program specifically designed to prevent fetal exposure to isotretinoin, a highly teratogenic retinoid. It requires prescriber, pharmacy, and patient enrollment, monthly pregnancy testing for patients who can become pregnant, and strict dispensing controls.
It is not designed for warfarin, digoxin, or finasteride.
References (Pharmacy Technician documents / Study Guides):
* REMS/iPLEDGE overview in pharm tech certification study guides-teratogenicity controls for isotretinoin.
* FDA-REMS framework content used in technician training on restricted distribution programs.